<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00579059</url>
  </required_header>
  <id_info>
    <org_study_id>62-U-007</org_study_id>
    <nct_id>NCT00579059</nct_id>
  </id_info>
  <brief_title>Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia</brief_title>
  <official_title>A Randomized Data Collection of the Maxim® Knee System With Removable Molded Polyethylene Tibia and the Regular Maxim® Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomet Orthopedics, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective clinical data collection is to compare the outcomes of two
      different tibial bearings: the Maxim® Pop-Top® Tibia and Maxim® Modular Tibia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this prospective clinical data collection is to document and compare the
      performance and clinical outcomes between the Maxim® Knee System with Removable Molded Poly
      Tibia and the Maxim® Knee System with Modular Tibial Bearing as two treatment groups.

      FDA has cleared these devices via Premarket Notification 510(k)'s K991753, K984623, K993159,
      K010027. The data gathered will be collated and used to provide feedback to designing
      engineers, support marketing efforts and answer potential questions from reimbursement
      agencies.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study sponsor canceled the study.
  </why_stopped>
  <start_date>May 2004</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee Society Function Score</measure>
    <time_frame>1 Year</time_frame>
    <description>The function score is detailed below as a Range; 100 being the highest score, and 0 being the lowest score. 90-100 is considered &quot;Excellent,&quot; 60-89 is considered &quot;Good,&quot; 30-59 is considered &quot;fair,&quot; and 0-29 is considered &quot;poor.&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Range of Motion - Flexion</measure>
    <time_frame>1 Year</time_frame>
    <description>This represents how far the patients were able to flex the knee in the clinic at 1-year.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Traumatic Arthritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Maxim® Pop-Top® Tibia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Maxim® Regular Tibia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Maxim® Knee System with Removable Molded Polyethylene Tibia</intervention_name>
    <description>Used for total knee replacements</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Maxim® Pop-Top® Tibia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Regular Maxim® Knee System</intervention_name>
    <description>Used for total knee replacements</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Modular Tibia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Identical to the indications stated in the FDA approved labeling for the device (cleared in
        510(k) K991753,

        K984623, K993159, K010027). These indications are stated below:

          -  Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis,
             traumatic arthritis where one or more compartments are involved.

          -  Correction of varus, valgus, or posttraumatic deformity.

          -  Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous
             joint replacement procedure.

        Patient selection factors to be considered include:

          -  need to obtain pain relief and improve function,

          -  ability and willingness of the patient to follow instructions, including control of
             weight and activity level,

          -  a good nutritional state of the patient,

          -  the patient must have reached full skeletal maturity.

          -  Porous coated knee joint replacement prostheses have not been approved for
             non-cemented applications in the United States.

        Exclusion Criteria:

        Identical to the contraindications stated in the FDA approved labeling for the device
        (cleared in 510(k) K991753, K984623, K993159, K010027's). These contraindications are
        stated below:

        Absolute contraindications include:

          -  infection,

          -  sepsis

          -  osteomyelitis.

        Relative contraindications include:

          -  uncooperative patient or patient with neurologic disorders who are incapable of
             following directions,

          -  Osteoporosis,

          -  metabolic disorders which may impair bone formation,

          -  osteomalacia,

          -  distant foci of infections which may spread to the implant site,

          -  rapid joint destruction, marked bone loss or bone resorption apparent on
             roentgenogram,

          -  vascular insufficiency, muscular atrophy, neuromuscular disease,

          -  incomplete or deficient soft tissue surrounding the knee.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Russell Wagner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harris Methodist Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Biomet Orthopedics, LLC</name>
      <address>
        <city>Warsaw</city>
        <state>Indiana</state>
        <zip>46581</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2007</study_first_submitted>
  <study_first_submitted_qc>December 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2007</study_first_posted>
  <results_first_submitted>May 20, 2009</results_first_submitted>
  <results_first_submitted_qc>May 20, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 7, 2009</results_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited by the investigator.</recruitment_details>
      <pre_assignment_details>There were no pre-assignment details to report.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Maxim® Pop-Top® Tibia</title>
          <description>tibia with removable polyethylene</description>
        </group>
        <group group_id="P2">
          <title>Maxim® Regular Tibia</title>
          <description>Tibia with Modular Polyethylene</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21">Enrollment was incomplete due to study cancellation.</participants>
                <participants group_id="P2" count="10">Enrollment was incomplete due to study cancellation.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Immediate Post-Op</title>
              <participants_list>
                <participants group_id="P1" count="20">1 Patient didn't return for follow-up.</participants>
                <participants group_id="P2" count="9">1 Patient didn't return for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>6 Months</title>
              <participants_list>
                <participants group_id="P1" count="11">10 Patients didn't return for follow-up.</participants>
                <participants group_id="P2" count="4">6 patients didn't return for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>1 Year</title>
              <participants_list>
                <participants group_id="P1" count="8">13 patients didn't return for follow-up.</participants>
                <participants group_id="P2" count="3">7 patients didn't return for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>3 Years</title>
              <participants_list>
                <participants group_id="P1" count="0">Incomplete due to study closure at 1-year of follow-up.</participants>
                <participants group_id="P2" count="0">Incomplete due to study closure at 1-year of follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>5 Years</title>
              <participants_list>
                <participants group_id="P1" count="0">Incomplete due to study closure at 1-year of follow-up.</participants>
                <participants group_id="P2" count="0">Incomplete due to study closure at 1-year of follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0">No Patients completed through 5 years due to study closure at 1-year of follow-up.</participants>
                <participants group_id="P2" count="0">No Patients completed through 5 years due to study closure at 1-year of follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Study Canceled at 1 Year</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Maxim® Pop-Top® Tibia</title>
          <description>tibia with removable polyethylene</description>
        </group>
        <group group_id="B2">
          <title>Maxim® Regular Tibia</title>
          <description>Tibia with Modular Polyethylene</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="31"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68" spread="8" lower_limit="53" upper_limit="82"/>
                    <measurement group_id="B2" value="62" spread="6" lower_limit="54" upper_limit="75"/>
                    <measurement group_id="B3" value="65" lower_limit="53" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="31.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Knee Society Function Score</title>
        <description>The function score is detailed below as a Range; 100 being the highest score, and 0 being the lowest score. 90-100 is considered &quot;Excellent,&quot; 60-89 is considered &quot;Good,&quot; 30-59 is considered &quot;fair,&quot; and 0-29 is considered &quot;poor.&quot;</description>
        <time_frame>1 Year</time_frame>
        <population>This population represents patients that returned for follow-up at 1-year post-op per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Maxim® Pop-Top® Tibia</title>
            <description>tibia with removable polyethylene</description>
          </group>
          <group group_id="O2">
            <title>Maxim® Regular Tibia</title>
            <description>Tibia with Modular Polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>Knee Society Function Score</title>
          <description>The function score is detailed below as a Range; 100 being the highest score, and 0 being the lowest score. 90-100 is considered &quot;Excellent,&quot; 60-89 is considered &quot;Good,&quot; 30-59 is considered &quot;fair,&quot; and 0-29 is considered &quot;poor.&quot;</description>
          <population>This population represents patients that returned for follow-up at 1-year post-op per protocol.</population>
          <units>knees</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>90-100</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60-89</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30-59</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Range of Motion - Flexion</title>
        <description>This represents how far the patients were able to flex the knee in the clinic at 1-year.</description>
        <time_frame>1 Year</time_frame>
        <population>This population represents patients that returned for follow-up at 1-year post-op per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Maxim® Pop-Top® Tibia</title>
            <description>tibia with removable polyethylene</description>
          </group>
          <group group_id="O2">
            <title>Maxim® Regular Tibia</title>
            <description>Tibia with Modular Polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion - Flexion</title>
          <description>This represents how far the patients were able to flex the knee in the clinic at 1-year.</description>
          <population>This population represents patients that returned for follow-up at 1-year post-op per protocol.</population>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118" lower_limit="100" upper_limit="130"/>
                    <measurement group_id="O2" value="113" lower_limit="105" upper_limit="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Not applicable - no adverse events were reported.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Maxim® Pop-Top® Tibia</title>
          <description>tibia with removable polyethylene</description>
        </group>
        <group group_id="E2">
          <title>Maxim® Regular Tibia</title>
          <description>Tibia with Modular Polyethylene</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Biomet owns copyright to database.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study was terminated after enrollment failed to produce sufficient data to be analyzed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Megan Lawson, Clinical Research Specialist</name_or_title>
      <organization>Biomet, LLC</organization>
      <phone>1-800-348-9500 ext 1183</phone>
      <email>megan.lawson@biomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

